Solid Dosage Outsourcing Trends
Author: Tim Wright
Wednesday, March 09, 2016
Kaspar van den Dries, director, research & development, Europe at Patheon, is featured in an article on solid dosage outsourcing trends published in Contract Pharma. The market continues to evolve as blockbusters are replaced by more targeted treatments that have unique requirements.
“There is a lot of capacity in solid dose manufacturing across the globe, so just having capacity is not necessarily a differentiator,” said Kaspar van den Dries, senior director and principal scientist of solid dose development, Patheon. “Pharmaceutical companies are looking for expanded services such as integrated API, drug product services and flexible manufacturing capacity to be able to handle the intrinsic variable demands, especially at the time of product launch.”
Please complete the short form below to download this whitepaper.